For research use only
| Cat No. | ABC-TC0697 |
| Product Type | Human Brain Cancer Cell Lines |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
MOG-G-UVW astrocytoma cells show epithelial morphology, telomerase-positive, ALT-negative, support HIV growth, ideal for brain and HIV research.
MOG-G-UVW is a human brain astrocytoma cell line that was originally isolated from the adult brain tissue of a male patient with anaplastic astrocytoma. These cells exhibit epithelial-like morphology and adhere well to culture surfaces. They are telomerase-positive and lack alternative lengthening of telomeres (ALT), distinguishing them from certain other glioma cell lines. A study of alternative lengthening of telomeres (ALT) inhibition in human glioma cell lines demonstrated that MOG-G-UVW are telomerase-positive and ALT-negative. MOG-G-UVW cells have been shown to support the growth of HIV, making them valuable for virology studies. Quality control measures ensure that these cells are free from mycoplasma, bacteria, yeast, and fungi, with high viability prior to freezing.
| Species | Human |
| Cat.No | ABC-TC0697 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Brain Cancer Cell Lines |
The MOG-G-UVW cell line is a valuable model for tumorigenicity studies of human anaplastic astrocytoma, enabling evaluation of growth factor receptor inhibitors alone or combined with radiation. It supports investigation of chemical effects on cell proliferation and the protective role of KATP channel openers. Additionally, MOG-G-UVW is used to study radiopharmaceutical applications of astatine-211 by analyzing its reduction patterns. The cell line also contributes to virus research, including HIV studies.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
